UPDATED May 23, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
INSP | US$154.82 | -2.6% | -47.8% | US$4.8b | US$250.73 | PS7x | E52.9% | n/a | ||
HIMS | US$15.83 | 12.7% | 75.3% | US$3.5b | US$17.17 | PS3.5x | E39.9% | n/a | ||
GDRX | US$7.24 | -10.2% | 38.2% | US$2.7b | US$9.40 | PS3.6x | E43.0% | n/a | ||
AMED | US$96.20 | 1.3% | 25.3% | US$3.2b | US$97.78 | PS1.4x | E68.4% | n/a | ||
NVST | US$17.97 | -6.1% | -45.5% | US$3.2b | US$20.50 | PS1.2x | E73.7% | n/a | ||
RCM | US$12.14 | -1.4% | -23.3% | US$5.1b | US$16.79 | PS2.2x | E54.2% | n/a | ||
EVH | US$22.89 | -1.8% | -21.3% | US$2.7b | US$41.71 | PS1.2x | E62.9% | n/a | ||
AXNX | US$67.33 | -0.5% | 35.6% | US$3.5b | US$71.80 | PS8.9x | E54.1% | n/a | ||
NARI | US$47.44 | 2.5% | -20.2% | US$2.8b | US$64.40 | PS5.3x | E73.9% | n/a | ||
LIVN | US$59.38 | -5.6% | 33.7% | US$3.3b | US$69.20 | PS2.7x | E41.2% | n/a | ||
CERT | US$16.53 | 0.4% | -22.0% | US$2.7b | US$19.72 | PS7.4x | E114.1% | n/a | ||
AGL | US$5.65 | 1.3% | -71.8% | US$2.5b | US$8.05 | PB3.4x | E62.9% | n/a | ||
CVET | US$20.99 | 0.5% | 5.6% | US$2.9b | US$21.50 | PB2x | S5.6% | n/a | ||
RXST | US$60.59 | -2.7% | 137.1% | US$2.4b | US$72.75 | PS23.4x | E49.2% | n/a | ||
NVCR | US$22.31 | 0.6% | -71.2% | US$2.6b | US$25.50 | PS4.6x | E5.1% | n/a | ||
PRCT | US$66.73 | -2.1% | 107.9% | US$3.4b | US$72.17 | PS22x | E40.8% | n/a | ||
TNDM | US$49.68 | 5.9% | 89.0% | US$3.3b | US$46.71 | PS4.2x | E54.3% | n/a |